CDC - Metabolomic Signatures Linking ALS to Persistent Organic Pollutant Exposures

Metabolomic Signatures Linking ALS to Persistent Organic Pollutant Exposures

Dr. Eva Feldman was awarded a CDC grant (R01TS000289) to examine how persistent organic pollutants affect the metabolism of ALS patients. The research will seek to identify differences in metabolites with low versus high persistent organic pollutant exposure to determine metabolomic signatures associated with these environmental exposures.  These findings could provide insight into ALS disease mechanisms and could serve as a “signature” that an individual has been exposed to POPs and could develop ALS.